Skip to content

Study · Measured the body's own peptide · 2002

1 result

Neurochemical phenotype of hypothalamic neurons showing Fos expression 23 h after intracranial AgRP.

Zheng H, Corkern MM, Crousillac SM, Patterson LM, Phifer CB, Berthoud HR

American journal of physiology. Regulatory, integrative and comparative physiology1 Jun 2002Cited by 52 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01AnimalEndogenous levelAnimal study (in vivo)Mechanism

    In rats, intracerebroventricular AgRP did not significantly change Fos expression in oxytocin neurons of the paraventricular nucleus versus saline.

    In plain wordsIn rats, AgRP did not change activity markers in the body's own oxytocin neurons compared with saline.

    Peptide
    Oxytocin
    Outcome
    No significant changeFos expression in paraventricular nucleus oxytocin neurons after AgRP
    Study

    ratn: not reported in source

    Comparator
    Saline
    Outcome group
    Receptor activity and mechanism · Nervous system and cognition

    Source sentences

    Summary
    In the paraventricular nucleus, there was no significant difference in Fos expression induced by AgRP vs. saline in oxytocin and CART neurons.
    1 context sentence
    Summary · context
    Thus we aimed to identify the neurochemical phenotype of some of these neurons in select hypothalamic areas, using double-label immunohistochemistry.

    This result measures the body's own Oxytocin. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 09:43 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:04 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 02:53 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.